MicroRNA-296-5p is differentially expressed in individuals with and without HIV-1 infection [PDF]
MicroRNAs are considered as potential biomarkers, agents, or therapeutic targets; few studies have addressed the expression of miRNAs in treatment-naïve patients infected with HIV-1.
Jhonathan Cárdenas-Bedoya +7 more
doaj +1 more source
Purpose: To investigate the role of peptidyl-prolyl cis/trans isomerase 1 (Pin1) on renal ischemia-reperfusion (I/R) injury and underlying mechanism. Methods: By establishing the in vitro and in vivo models of renal I/R, the role of Pin1 was explored by
Honglin Yu +3 more
doaj +1 more source
Single nucleotide polymorphisms of PIN1 promoter region and cancer risk: evidence from a meta-analysis. [PDF]
Peptidylprolyl cis/trans isomerase NIMA-interacting 1 (PIN1) is involved in the process of tumorigenesis. The two single nucleotide polymorphisms (-677T>C, -842G>C) in the PIN1 promoter region have been suspected of being associated with cancer risk for ...
Jing-Jing Peng +7 more
doaj +1 more source
Su Wan,1 Guantai Ni,1 Jin Ding,1 Yuansheng Huang2 1Department of Obstetrics and Gynecology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui 241000, People’s Republic of China; 2Department of Orthopedics, Yijishan Hospital of Wannan Medical
Wan S, Ni G, Ding J, Huang Y
doaj
MicroRNA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regulating peptidyl-prolyl cis/trans isomerase. [PDF]
Chen H, Cai X, Du B, Cai J, Luo Z.
europepmc +1 more source
Deep Proteomic Compound Profiling with the Orbitrap Ascend Tribrid Mass Spectrometer Using Tandem Mass Tags and Real-Time Search. [PDF]
Shuken SR +11 more
europepmc +1 more source
Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell Lines. [PDF]
Kanna M +8 more
europepmc +1 more source
Based on 3D-QSAR modeling and molecular dynamics of novel peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 inhibitors design and screening. [PDF]
Xu D, Li J, Li Y, Dou J.
europepmc +1 more source
The Effect of Prolyl Isomerase Pin1 on the Development of Metabolic Dysfunction-Associated Steatohepatitis and a New Treatment Strategy. [PDF]
Matsunaga Y +4 more
europepmc +1 more source
Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension. [PDF]
Rai N +12 more
europepmc +1 more source

